Development of a predictive model for FGF-23 levels in children with chronic kidney disease

被引：0
|
作者：
Balmukhanova, Altynay [1 ,2 ]
Kabulbayev, Kairat [2 ]
Alpay, Harika [3 ]
Balmukhanova, Aigul [4 ]
Kanatbayeva, Assiya [2 ]
机构：
[1] Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan
[2] Asfendiyarov Kazakh Natl Med Univ, Alma Ata, Kazakhstan
[3] Marmara Univ, Istanbul, Turkiye
[4] Caspian Univ, Alma Ata, Kazakhstan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2611
引用
收藏
页码：I908 / I908
页数：1
相关论文
共 50 条
  • [31] Role of Morphogenetic Proteins - FGF-23 and Klotho in the Vascular Calcification in Patients with Chronic Kidney Disease
    Plotnikova, Alexandra
    Milovanova, Ludmila
    Milovanov, Yurii
    Moiseyev, Sergey
    Kozlovskaya, Lydia
    Mukhin, Nikolay
    Kryukova, Daria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [32] IL-1β Drives Production of FGF-23 at the Onset of Chronic Kidney Disease in Mice
    McKnight, Quiana
    Jenkins, Sarah
    Li, Xiuqi
    Nelson, Tracy
    Marlier, Arnaud
    Cantley, Lloyd G.
    Finberg, Karin E.
    Fretz, Jackie A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (07) : 1352 - 1362
  • [33] Zinc Supplementation Trial in Pediatric Chronic Kidney Disease: Effects on Circulating FGF-23 and Klotho
    Belostotsky, V.
    Atkinson, S. A.
    Filler, G.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2024, 11
  • [34] Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
    Muras-Szwedziak, Katarzyna
    Pawlowicz-Szlarska, Ewa
    Nowicki, Michal
    RENAL FAILURE, 2023, 45 (01)
  • [35] Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease
    Finch, Jane L.
    Tokumoto, Masanori
    Nakamura, Hironori
    Yao, Wei
    Shahnazari, Mohammad
    Lane, Nancy
    Slatopolsky, Eduardo
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 298 (06) : F1315 - F1322
  • [36] FGF-23, SKLOTHO AND SCLEROSTIN IN ASPECT OF VASCULAR CALCIFICATION IN RUSSIAN CHRONIC KIDNEY DISEASE PATIENTS
    Milovanova, Ludmila
    Lysenko , Lidia
    Vervloet, Marc
    Fomin, Victor
    Milovanov, Yuriy
    Kozlov, Vasiliy
    Taranova, Marina
    Milovanova, Svetlana
    Reshetnikov, Vladimir
    Kozevnikova, Elena
    Brovko, Mihail
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [37] EFFECT OF PIOGLITAZONE ON SERUM FGF-23 LEVELS IN PATIENTS WITH DIABETIC KIDNEY DISEASE: A RANDOMIZED CONTROLLED TRIAL
    Triwatana, Wutipong
    Inkong, Pitchamon
    Tasanavipas, Pamila
    Varothai, Narittaya
    Thimachai, Paramat
    Chaiprasert, Amnart
    Nata, Naowanit
    Supasyndh, Ouppatham
    Satirapoj, Bancha
    NEPHROLOGY, 2021, 26 : 37 - 37
  • [38] IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS
    Milovanov, Yuriy
    Dudareva, Anna
    Milovanova, Ludmila
    Kozlovskaya, Lidia
    Mukhin, Nikolay
    Lebedeva, Marina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1469 - 1470
  • [39] Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease
    Lin, Jiabao
    Lin, Luqi
    Chen, Siyu
    Yu, Lifang
    Chen, Songjie
    Xia, Zhaofei
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2021, 33 (02) : 288 - 293
  • [40] FGF-23 and osteocalcin levels are not associated with cardiovascular manifestations in Fabry disease
    Rosa Neto, Nilton S.
    Bento, Judith C. B.
    Caparbo, Valeria F.
    Pereira, Rosa Maria R.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S137 - S137
12345